LESU:F:F-Amundi MSCI USA ESG Leaders Extra UCITS ETF DR – USD (D) (EUR)

ETF | Others |

Last Closing

USD 44.54

Change

-0.06 (-0.13)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

-0.08 (-0.01%)

USD 111.88B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.26 (+0.50%)

USD 106.38B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 105.77B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.07 (+0.47%)

USD 62.83B
VUSA:F Vanguard Funds Public Limited ..

-0.19 (-0.17%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 51.55B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 43.00B
0ZC:F Zscaler Inc

+5.38 (+2.96%)

USD 37.92B
BSND:F Danone SA

+0.10 (+0.75%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.58 (+0.43%)

USD 24.77B

ETFs Containing LESU:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.72% 11% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.72% 11% F 32% F
Trailing 12 Months  
Capital Gain 17.77% 73% C 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.77% 69% C- 57% F
Trailing 5 Years  
Capital Gain 120.77% 94% A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 120.77% 94% A 67% D+
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike